Huntleigh Advisors »

Adaptive Biotechnologies Cor shares owned by Huntleigh Advisors

Quarter-by-quarter ownership of Adaptive Biotechnologies Cor (ADPT) shares owned by Huntleigh Advisors from 13F filings

Historical chart of Huntleigh Advisors investment in Adaptive Biotechnologies Cor

Tip: Access up to 7 years of quarterly data

All positions including Adaptive Biotechnologies Cor held by Huntleigh Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptive Biotechnologies Cor by Huntleigh Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 82k 14.96

More positions owned by Huntleigh Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Oracle Corporation (ORCL)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Ab Active Etfs Short Duration H (SYFI)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amphenol Corp Cl A (APH)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Blackrock (BLK)

View all positions for Huntleigh Advisors

Top funds holding Adaptive Biotechnologies Cor

Viking Global Investors
BlackRock
Vanguard Group
Ameriprise Financial
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
ARK Investment Management
Aristotle Atlantic Partners
State Street Corporation
Driehaus Capital Management
Fred Alger Management
Arrowstreet Capital, Limited Partnership
Blue Water Life Science Advisors
Macquarie Group

View all funds holding Adaptive Biotechnologies Cor